T. Rowe Price Investment Management, Inc. - HILLEVAX INC ownership

HILLEVAX INC's ticker is and the CUSIP is 43157M102. A total of 56 filers reported holding HILLEVAX INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
T. Rowe Price Investment Management, Inc. ownership history of HILLEVAX INC
ValueSharesWeighting
Q3 2023$19,260
-21.4%
1,431,968
+0.5%
0.01%
-17.6%
Q2 2023$24,495
+22.3%
1,424,935
+17.6%
0.02%
+21.4%
Q1 2023$20,026
-1.2%
1,211,492
+0.0%
0.01%
-12.5%
Q4 2022$20,266
-99.9%
1,211,322
+10.1%
0.02%
+6.7%
Q3 2022$18,799,0001,100,0000.02%
Other shareholders
HILLEVAX INC shareholders Q4 2022
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 558,923$7,517,5149.98%
Frazier Life Sciences Management, L.P. 9,781,472$131,560,7988.74%
Samsara BioCapital, LLC 799,274$10,750,2353.29%
VR Adviser, LLC 2,037,313$27,401,8602.88%
StepStone Group LP 826,567$11,117,3262.48%
ACUTA CAPITAL PARTNERS, LLC 270,319$3,635,7912.44%
Deep Track Capital, LP 2,900,000$39,005,0001.51%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,004,231$53,856,9071.19%
Carlyle Group Inc. 1,838,486$24,690,8671.07%
Monashee Investment Management LLC 110,000$1,479,5000.62%
View complete list of HILLEVAX INC shareholders